Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SEB Investment Management is a leading Nordic asset manager and a subsidiary of the Skandinaviska Enskilda Banken (SEB) Group. The firm manages a diverse range of investment funds, including the specialized SEB Healthcare Fund, which focuses on global investments in the pharmaceutical, biotechnology, and medical technology sectors. While not a developer of therapeutics, the company is a significant institutional investor in the life sciences industry, utilizing fundamental analysis to identify growth opportunities in healthcare innovation. SEB Investment Management is recognized for its commitment to sustainable investment and the integration of ESG criteria across its portfolio. The firm provides investment solutions to both retail and institutional clients across international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SEB Investment Management.